Sept 17, 2019—New York, US Facing the challenge that the need of bioinformatics analysis is climbing and not all research institutes or drug manufacturers hold such techniques, Creative Biolabs bends every effort to solve the problems, aiming to speed up relevant projects and perfect the research result as much as possible with its comprehensive NGS bioinformatics analysis solutions, including whole genome sequencing (WGS), whole exome sequencing (WES), targeted sequencing, whole transcriptome sequencing (WTS) and immune repertoire sequencing.
The SuPrecisionTM is capable of conducting large-scale calculation of next generation sequencing with its embed latest statistical methods and bioinformatics tools.
1. The Whole Genome Sequencing (WGS) Bioinformatics Analysis accepts large scale data to be handled at an insuperable turnaround. Highly precise as it is, the WGS analysis pipeline follows a systematic workflow.
1) primary screening of raw data
2) producing clean data
3) unspliced mapping of the clean data onto a reference genome
4) post-alignment processing
5) quality control of the mapped reads
6) variant calling, annotation and prioritization
2. Whole Exome Sequencing (WES) Bioinformatic Analysis follows similar procedures with those of WGS, whose technologies have been updated from the experimental data to computationally intensive informatics-based data through adopting abreast-of-the-art computational techniques, and it is now taken as an optimal means of detecting the single nucleotide variants (SNV). As precise as the solutions can be, the data will be kept for a long time securely to make convenient for check at any time.
3. Whole transcriptome analysis fundamentally solves biological issues and assist with understanding the molecular mechanisms of many diseases, like human cancer. Whole transcriptome sequencing (other names: RNA sequencing) works on RNA molecule transcripts. Cancer WTS solutions from Creative Biolabs allow discovering and profiling RNAs without prior genome annotation, including mRNA Sequencing, miRNA Sequencing, CircRNA Sequencing, LncRNA Sequencing and Exosome RNA Sequencing.
4. The comprehensive targeted sequencing bioinformatics analysis is designed to meet a variety of objectives, which allows adjustments according to specific requirements. The application range is broad, covering germline or somatic mutations discovery, rare variants detection and quantification, identification of biomarkers associated with a disease state, etc. Supported by scientists, convincing results are delivered in a short cycle, in depth, comprehensively, and precisely.
Other regarding solutions like the immune repertoire bioinformatics analysis are accessible, equipped with the world-leading technology platforms and professional scientific staff. “Through our high-throughput and automated system, clients could accelerate their research with the most comprehensive information in a time-saving manner,” said the head of Creative Biolabs, who will never stop his steps to move forward in the NGS area. If more information about the SuPrecisionTM platform or the services is required, please visit the official website https://www.creative-biolabs.com/suprecision/.
About the Company
Established in 2004, Creative Biolabs is a leading customer service provider in the field of next-generation sequencing (NGS). With years of research and development experience, a pioneer SuPrecision™ platform has been successfully established to offer accurate and high-throughput sequencing services to meet every unique requirement of global clients.
Media ContactCompany Name: Creative BiolabsContact Person: Candy SwiftEmail: Send EmailPhone: 1-631-619-7922Address:45-1 Ramsey Road City: ShirleyState: New YorkCountry: United StatesWebsite: https://www.creative-biolabs.com/suprecision/
